Trial description:
Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer
Contact name:
Dr David Gilligan
Trial start date:
Tuesday, November 17, 2015
Trial end date:
Thursday, December 31, 2020
Trial tumour type:
Lung
Show on Radiotherapy:
No
